Search
for
Sort by
Research 301–330 of 1000+
- TGFβ family mimetic peptide promotes proliferation of human hair follicle dermal papilla cells and hair growth in C57BL/6 mice
- Genome-Wide Association Study of Alopecia Areata in Taiwan: The Conflict Between Individuals and Hair Follicles
- 915 Dietary grape powder inhibits atopic dermatitis-like skin lesions in NC/Nga mice
- The role of lymphocytes in the development and treatment of alopecia areata
- The regeneration blastema of lizards: an amniote model for the study of appendage replacement
- Regulation of melanocyte stem cell behavior by the niche microenvironment
- Overexpression of Lnk in the Ovaries Is Involved in Insulin Resistance in Women With Polycystic Ovary Syndrome
- Dermal papilla regulation of hair growth and pigmentation
- Skin aging: mechanisms, evaluation, and rejuvenation
- Use of genetics in the prediction of success in male pattern hair loss therapy and mechanistic studies
- Tissue engineering strategies for human hair follicle regeneration: How far from a hairy goal?
- JAK inhibitors in dermatology: The promise of a new drug class
- Selective inhibition of JAK3 signaling is sufficient to reverse alopecia areata
- JAK inhibition decreases the autoimmune burden in Down syndrome
- JAK inhibition decreases the autoimmune burden in Down syndrome
- Association of JAK 1 and JAK 2 gene polymorphism with alopecia areata risk: a case–control genetic study
- ROS-responsive hydrogel-delivered miR-665 targets STAT3 to alleviate inflammation and promote hair follicle regeneration in alopecia areata
- JAK-Inhibitors Beyond the Label: Emerging Applications in Dermatology
- JAK Inhibitors for Treatment of Alopecia Areata
- A Comprehensive Literature Review of JAK Inhibitors in Treatment of Alopecia Areata
- Simultaneous improvement of alopecia universalis and atopic dermatitis in a patient treated with a JAK inhibitor
- Post-marketing safety signals of four JAK inhibitors for alopecia areata: an indication-restricted FAERS pharmacovigilance study
- Short-term malignancy risk of JAK inhibitors in severe alopecia areata: a multicenter cohort study
- Short-term Efficacy of Tofacitinib, a JAK Inhibitor, in IFIH1-related Aicardi-Goutières Syndrome
- Comparative efficacy and safety of JAK inhibitors in the treatment of moderate-to-severe alopecia areata: a systematic review and network meta-analysis
- Screening for latent infectious disease in patients with alopecia areata before initiating JAK inhibitors therapy: a single-center real-world retrospective study
- The efficacy and safety of JAK inhibitors for alopecia areata: A systematic review and meta-analysis of prospective studies
- JAK 1-3 inhibitors and TYK-2 inhibitors in dermatology: Practical pearls for the primary care physician
- LB1034 Meta-analysis of scalp transcriptome defines alopecia areata subtypes and molecular response to four (4) treatments with jak inhibiting properties
- Translational Positioning of Janus Kinase (JAK) Inhibitors in Alopecia Areata